# Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma

> **NCT01429961** · PHASE2 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 38 (estimated)

## Conditions studied

- Advanced Hepatocellular Carcinoma

## Interventions

- **DRUG:** SOX

## Key facts

- **NCT ID:** NCT01429961
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2011-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01429961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01429961, "Trial of Palliative Chemotherapy With TS-1 and Oxaliplatin for Patients With Advanced Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01429961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*